Ergebnis der Suchanfrage nach Siegen

Plansecur KG

Lamia Messari-Becker is named “Thought Leader 2024“

SYNformulas GmbH

2

Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation

K+S Aktiengesellschaft

EANS-News: K+S Aktiengesellschaft / Changes in the Board of Executive Directors

Changes in the Board of Executive Directors Further inquiry note: Oliver Morgenthal Phone: +49 561 9301 1047 Fax: +49 561 9301 2160 oliver.morgenthal@k-plus-s.com Branche: Chemicals ISIN: DE0007162000 WKN: 716200 Index: DAX, Midcap Market Index, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / regulated ...